scholarly article | Q13442814 |
P50 | author | Jay Shendure | Q15989781 |
Donna A. Santillan | Q38319233 | ||
Mark K Santillan | Q58002761 | ||
P2093 | author name string | Hilary S Gammill | |
Jacob O Kitzman | |||
LaVone E Simmons | |||
Matthew W Snyder | |||
P2860 | cites work | ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal Abnormalities | Q22242787 |
Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting | Q24598225 | ||
Targeted capture and massively parallel sequencing of 12 human exomes | Q24615381 | ||
Rate of de novo mutations and the importance of father's age to disease risk | Q24632353 | ||
Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
Accuracy of cytogenetic findings on chorionic villus sampling (CVS)--diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centres contributing to EUCROMIC 1986-1992 | Q28250247 | ||
Chromosomal mosaicism confined to the placenta in human conceptions | Q28275224 | ||
Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders | Q28279421 | ||
Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. | Q30704921 | ||
Haplotype-resolved genome sequencing of a Gujarati Indian individual. | Q33775428 | ||
Direct determination of molecular haplotypes by chromosome microdissection. | Q33854525 | ||
Whole-genome molecular haplotyping of single cells | Q33902780 | ||
Loss of mismatched HLA in leukemia after stem-cell transplantation. | Q34018719 | ||
Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10 | Q34134419 | ||
Non-invasive prenatal measurement of the fetal genome | Q34286073 | ||
Accurate whole-genome sequencing and haplotyping from 10 to 20 human cells. | Q34287418 | ||
Completely phased genome sequencing through chromosome sorting | Q34472137 | ||
Georg Schmorl on trophoblasts in the maternal circulation | Q34566588 | ||
Karyotype versus microarray testing for genetic abnormalities after stillbirth | Q34966044 | ||
Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. | Q35221979 | ||
Digital PCR for the molecular detection of fetal chromosomal aneuploidy | Q35916813 | ||
Noninvasive whole-genome sequencing of a human fetus. | Q36048523 | ||
The otherness of self: microchimerism in health and disease | Q36450729 | ||
A fascination with chromosome rescue in uniparental disomy: Mendelian recessive outlaws and imprinting copyrights infringements | Q36488731 | ||
Chromosomal microarray versus karyotyping for prenatal diagnosis | Q36546668 | ||
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma | Q37010246 | ||
Carrier testing for severe childhood recessive diseases by next-generation sequencing | Q37086582 | ||
The expanding scope of DNA sequencing | Q38058682 | ||
aCGH on chorionic villi mirrors the complexity of fetoplacental mosaicism in prenatal diagnosis | Q39586170 | ||
Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing | Q47427812 | ||
FetalQuant: deducing fractional fetal DNA concentration from massively parallel sequencing of DNA in maternal plasma | Q47960026 | ||
Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing. | Q53288194 | ||
Fetal lymphocytes in the maternal blood. | Q53873799 | ||
Mosaicism for genome-wide paternal uniparental disomy with features of multiple imprinting disorders: diagnostic and management issues. | Q54279468 | ||
Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus | Q56937251 | ||
Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
Non-invasive fetal genome sequencing: opportunities and challenges | Q57201829 | ||
Fetal aneuploidy screening by maternal plasma DNA sequencing: ‘False positive’ due to confined placental mosaicism | Q58028950 | ||
An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities | Q72729435 | ||
Fetal karyotyping by chorionic villus sampling after the first trimester | Q73078539 | ||
Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma | Q77372981 | ||
ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy | Q80138010 | ||
Reevaluating confined placental mosaicism | Q80969761 | ||
Noninvasive prenatal diagnosis using fetal cells in maternal blood | Q83530320 | ||
Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy | Q85495453 | ||
P433 | issue | 6 | |
P921 | main subject | whole genome sequencing | Q2068526 |
P304 | page(s) | 547-554 | |
P577 | publication date | 2013-04-01 | |
P1433 | published in | Prenatal Diagnosis | Q15760059 |
P1476 | title | Noninvasive fetal genome sequencing: a primer | |
P478 | volume | 33 |
Q55173016 | "This lifetime commitment": Public conceptions of disability and noninvasive prenatal genetic screening. |
Q64077212 | Bayesian-based noninvasive prenatal diagnosis of single-gene disorders |
Q38509263 | Cell-free DNA versus intact fetal cells for prenatal genetic diagnostics: what does the future hold? |
Q46914667 | Current controversies in prenatal diagnosis 1: should noninvasive DNA testing be the standard screening test for Down syndrome in all pregnant women? |
Q35089024 | DFLAT: functional annotation for human development |
Q35691099 | Defining "mutation" and "polymorphism" in the era of personal genomics |
Q57839567 | Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities |
Q39181228 | Future of whole genome sequencing. |
Q33833207 | Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research |
Q36787475 | Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? |
Q38559682 | Microarray Technology for the Diagnosis of Fetal Chromosomal Aberrations: Which Platform Should We Use? |
Q48240788 | Noninvasive prenatal testing: the paradigm is shifting rapidly |
Search more.